Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Neutral

Analyst Rating

Strong Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Collegium Pharmaceutical, Inc. Common Stock (COLL)

Pharmaceutical Preparations

https://www.collegiumpharma.com

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.

100 TECHNOLOGY CENTER DRIVE
STOUGHTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/07/2015

Market Cap

1,141,496,003

Shares Outstanding

32,610,000

Weighted SO

32,610,873

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

PAHC --.--%

ANIP --.--%

ANIP --.--%

PROC --.--%

PROC --.--%

SSIC --.--%

SSIC --.--%

AMPH --.--%

AMPH --.--%

Beta

0.9260

Last Div

0.0000

Range

20.95-40.95

Chg

-0.0450

Avg Vol

500380

Mkt Cap

1141496003

Exch

NASDAQ

Country

US

Phone

781 713 3699

DCF Diff

-28.3607

DCF

63.6807

Div Yield

0.0000

P/S

1.9795

EV Multiple

4.2923

P/FV

5.3063

Div Yield %

0.0000

P/E

11.5050

PEG

0.5510

Payout

0.0000

Current Ratio

1.1050

Quick Ratio

1.0447

Cash Ratio

0.3745

DSO

116.3734

DIO

46.3414

Op Cycle

162.7149

DPO

4.0118

CCC

158.7031

Gross Margin

0.6194

Op Margin

0.3532

Pretax Margin

0.2449

Net Margin

0.1732

Eff Tax Rate

0.2926

ROA

0.0948

ROE

0.4914

ROCE

0.3442

NI/EBT

0.7074

EBT/EBIT

0.6934

EBIT/Rev

0.3532

Debt Ratio

0.5258

D/E

2.5573

LT Debt/Cap

0.6305

Total Debt/Cap

0.7189

Int Coverage

4.8718

CF/Debt

0.4996

Equity Multi

4.8637

Rec Turnover

3.1365

Pay Turnover

90.9826

Inv Turnover

7.8763

FA Turnover

28.0364

Asset Turnover

0.5474

OCF/Share

8.5311

FCF/Share

8.4983

Cash/Share

8.3751

OCF/Sales

0.4798

FCF/OCF

0.9961

CF Coverage

0.4996

ST Coverage

1.5007

CapEx Coverage

259.3168

Div&CapEx Cov

259.3168

P/BV

5.3063

P/B

5.3063

P/S

1.9795

P/E

11.5050

P/FCF

4.1415

P/OCF

4.1536

P/CF

4.1536

PEG

0.5510

P/S

1.9795

EV Multiple

4.2923

P/FV

5.3063

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Mar 10, 22:57 Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care Seeking Alpha Jan 13, 10:30 Stocks To Watch: Energy Market Drama And Financial Earnings Headline Holiday Week Seeking Alpha Jan 13, 10:30 Stocks To Watch: Energy Market Drama And Financial Earnings Headline Holiday Week Zacks Investment Research Jan 04, 03:17 Strength Seen in Collegium Pharmaceutical (COLL): Can Its 8.4% Jump Turn into More Strength?

Revenue Product Segmentation